Iuliia Kovalenko

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Iuliia Kovalenko

Dec 23, 2024, 13:21 | Insight

Emanuele Crupi: Antiangiogenic Therapy Combined with Immune Checkpoint Blockade in Urothelial Cancer

Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn…

Dec 22, 2024, 11:44 | Insight

Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer

Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X:…

Jan 12, 2024, 23:00 | Insight

Iuliia Kovalenko: Tweetorial that explores the toxicity profile of combining immune checkpoint therapy with (VEGFi) in various cancer treatment

Iuliia Kovalenko, PGY-3 IM resident at UPMC Harrisburg, shared the following thread on X: "In…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023